Variables | EP approach | TP approach | p-Value |
---|---|---|---|
Patients (n) | 190 | 190 | Â |
Follow-up (months) | 27.3 ± 13.8 (4–52) | 27.8 ± 154.3 (4–52) | 0.78 |
Age (years) | 69.4 ± 6.0 (51–82) | 69.3 ± 4.7 (51–79) | 0.70 |
Height (cm) | 165.2 ± 6.1 (143.6–186.0) | 165.4 ± 5.3 (152.5–183.2) | 0.70 |
Weight (kg) | 63.7 ± 9.3 (34.8–103.0) | 63.6 ± 9.4 (38.0–122.0) | 0.89 |
BMI (kg/m2) | 23.3 ± 3.0 (16.9–34.5) | 23.2 ± 2.9 (15.8–36.3) | 0.73 |
PSA (ng/mL) | 10.7 ± 11.6 (2.2–84.4) | 10.8 ± 10.4 (2.3–73.1) | 0.24 |
Biopsy Gleason score (%) | Â | Â | 0.12 |
 2–6 | 36 (19.0) | 44 (23.2) |  |
 7 | 100 (52.6) | 80 (42.1) |  |
 8–10 | 54 (28.4) | 66 (34.7) |  |
Clinical stage (%) | Â | Â | 0.15 |
 T1 | 41 (21.6) | 49 (25.8) |  |
 T2 | 142 (74.7) | 126 (66.3) |  |
 T3 | 7 (3.7) | 15 (7.9) |  |
Previous abdominal surgery (%) | 62 (32.3) | 65 (35.4) | 0.91 |